| Seaside Psychotherapy Gulf Coast | |
|
2113 Government St Ste I-2e Ocean Springs MS 39564-3954 | |
| (228) 222-8006 | |
| Not Available |
| Full Name | Seaside Psychotherapy Gulf Coast |
|---|---|
| Speciality | Social Worker |
| Location | 2113 Government St Ste I-2e, Ocean Springs, Mississippi |
| Authorized Official Name and Position | Ashley P Pearson (OWNER) |
| Authorized Official Contact | 5043192837 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Seaside Psychotherapy Gulf Coast 3818 Chaumont Cir Ocean Springs MS 39564-8539 Ph: (504) 319-2837 | Seaside Psychotherapy Gulf Coast 2113 Government St Ste I-2e Ocean Springs MS 39564-3954 Ph: (228) 222-8006 |
| NPI Number | 1265088306 |
|---|---|
| Provider Enumeration Date | 08/14/2019 |
| Last Update Date | 09/15/2019 |
| Medicare PECOS PAC ID | 9032541461 |
|---|---|
| Medicare Enrollment ID | O20191122001892 |
News Archive
A team of international cancer researchers led by Dr. Mathieu Lupien at the Princess Margaret Cancer Centre, University Health Network, has identified the signalling pathway that is over-activated in estrogen receptor (ER)-positive breast cancer cells that are resistant to hormone therapies such as tamoxifen, aromatase inhibitors or fulvestrant.
A pint of milk a day could be back in fashion again following the results of a new study which says dairy foods can protect against metabolic syndrome.
The first report of the presence of alternative lengthening of telomeres (ALT) in cancers arising from the bladder, cervix, endometrium, esophagus, gallbladder, liver, and lung was published today in The American Journal of Pathology. The presence of ALT in carcinomas can be used as a diagnostic marker and has implications for the development of anti-cancer drug therapies.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265088306 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Ashley Pugeau Pearson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1134296809 PECOS PAC ID: 7618028275 Enrollment ID: I20110228000227 |
News Archive
A team of international cancer researchers led by Dr. Mathieu Lupien at the Princess Margaret Cancer Centre, University Health Network, has identified the signalling pathway that is over-activated in estrogen receptor (ER)-positive breast cancer cells that are resistant to hormone therapies such as tamoxifen, aromatase inhibitors or fulvestrant.
A pint of milk a day could be back in fashion again following the results of a new study which says dairy foods can protect against metabolic syndrome.
The first report of the presence of alternative lengthening of telomeres (ALT) in cancers arising from the bladder, cervix, endometrium, esophagus, gallbladder, liver, and lung was published today in The American Journal of Pathology. The presence of ALT in carcinomas can be used as a diagnostic marker and has implications for the development of anti-cancer drug therapies.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 4 days ago
News Archive
A team of international cancer researchers led by Dr. Mathieu Lupien at the Princess Margaret Cancer Centre, University Health Network, has identified the signalling pathway that is over-activated in estrogen receptor (ER)-positive breast cancer cells that are resistant to hormone therapies such as tamoxifen, aromatase inhibitors or fulvestrant.
A pint of milk a day could be back in fashion again following the results of a new study which says dairy foods can protect against metabolic syndrome.
The first report of the presence of alternative lengthening of telomeres (ALT) in cancers arising from the bladder, cervix, endometrium, esophagus, gallbladder, liver, and lung was published today in The American Journal of Pathology. The presence of ALT in carcinomas can be used as a diagnostic marker and has implications for the development of anti-cancer drug therapies.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 4 days ago
Carrie Virginia Pate Therapy Center, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2112 Bienville Blvd, Suite L-1, Ocean Springs, MS 39564 Phone: 228-990-8980 Fax: 228-215-1721 | |
Ocean Springs Hospital Professional Fees Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3109 Bienville Blvd, Ocean Springs, MS 39564 Phone: 228-818-1111 | |
Family Focused Health Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2112 Bienville Blvd # 443, Ocean Springs, MS 39564 Phone: 228-382-3107 Fax: 800-854-0906 | |
Empowered Pathways, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1206 Hillcrest Dr, Ocean Springs, MS 39564 Phone: 228-217-2997 Fax: 228-250-1399 | |
Phoenix Behavioral Health Center, Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2112 Bienville Blvd Ste K, Ocean Springs, MS 39564 Phone: 228-819-2171 Fax: 228-205-4986 | |
Parker Family Counseling Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7921 Rue Madison, Ocean Springs, MS 39564 Phone: 228-217-0119 | |
Tina J Sullivan Counseling Services Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 609 Washington Ave, Ocean Springs, MS 39564 Phone: 662-251-3245 |